ID   HERC1_HUMAN             Reviewed;        4861 AA.
AC   Q15751; Q8IW65;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   10-MAY-2017, entry version 152.
DE   RecName: Full=Probable E3 ubiquitin-protein ligase HERC1;
DE            EC=2.3.2.26;
DE   AltName: Full=HECT domain and RCC1-like domain-containing protein 1;
DE   AltName: Full=HECT-type E3 ubiquitin transferase HERC1;
DE   AltName: Full=p532;
DE   AltName: Full=p619;
GN   Name=HERC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INTERACTION WITH ARF1, AND VARIANTS ALA-1696; VAL-2220
RP   AND ASP-3722.
RX   PubMed=8861955;
RA   Rosa J.L., Casaroli-Marano R.P., Buckler A.J., Vilaro S., Barbacid M.;
RT   "p619, a giant protein related to the chromosome condensation
RT   regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab
RT   proteins.";
RL   EMBO J. 15:4262-4273(1996).
RN   [2]
RP   ERRATUM.
RA   Rosa J.L., Casaroli-Marano R.P., Buckler A.J., Vilaro S., Barbacid M.;
RL   EMBO J. 15:5738-5738(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4211-4861.
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH CLTC.
RX   PubMed=9233772; DOI=10.1038/sj.onc.1201170;
RA   Rosa J.L., Barbacid M.;
RT   "A giant protein that stimulates guanine nucleotide exchange on ARF1
RT   and Rab proteins forms a cytosolic ternary complex with clathrin and
RT   Hsp70.";
RL   Oncogene 15:1-6(1997).
RN   [6]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PKM.
RX   PubMed=12650930; DOI=10.1016/S0014-5793(03)00205-9;
RA   Garcia-Gonzalo F.R., Cruz C., Munoz P., Mazurek S., Eigenbrodt E.,
RA   Ventura F., Bartrons R., Rosa J.L.;
RT   "Interaction between HERC1 and M2-type pyruvate kinase.";
RL   FEBS Lett. 539:78-84(2003).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=14960311; DOI=10.1016/S0014-5793(04)00030-4;
RA   Garcia-Gonzalo F.R., Munoz P., Gonzalez E., Casaroli-Marano R.P.,
RA   Vilaro S., Bartrons R., Ventura F., Rosa J.L.;
RT   "The giant protein HERC1 is recruited to aluminum fluoride-induced
RT   actin-rich surface protrusions in HeLa cells.";
RL   FEBS Lett. 559:77-83(2004).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH ARF6.
RX   PubMed=15642342; DOI=10.1016/j.febslet.2004.11.095;
RA   Garcia-Gonzalo F.R., Bartrons R., Ventura F., Rosa J.L.;
RT   "Requirement of phosphatidylinositol-4,5-bisphosphate for HERC1-
RT   mediated guanine nucleotide release from ARF proteins.";
RL   FEBS Lett. 579:343-348(2005).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   INTERACTION WITH TSC2.
RX   PubMed=16464865; DOI=10.1074/jbc.C500451200;
RA   Chong-Kopera H., Inoki K., Li Y., Zhu T., Garcia-Gonzalo F.R.,
RA   Rosa J.L., Guan K.-L.;
RT   "TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and
RT   the HERC1 ubiquitin ligase.";
RL   J. Biol. Chem. 281:8313-8316(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1521, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-2701, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1517; SER-1521;
RP   THR-2701; SER-2706 AND SER-2710, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1521 AND THR-2701, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4857, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1491, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1342; SER-1428;
RP   SER-1512; SER-1521; SER-2422; THR-2701; SER-2720 AND SER-2723, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1406 AND SER-1512, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   INVOLVEMENT IN MDFPMR, AND VARIANT MDFPMR GLU-4520.
RX   PubMed=26138117; DOI=10.1111/cge.12634;
RA   Ortega-Recalde O., Beltran O.I., Galvez J.M., Palma-Montero A.,
RA   Restrepo C.M., Mateus H.E., Laissue P.;
RT   "Biallelic HERC1 mutations in a syndromic form of overgrowth and
RT   intellectual disability.";
RL   Clin. Genet. 88:E1-E3(2015).
CC   -!- FUNCTION: Involved in membrane trafficking via some guanine
CC       nucleotide exchange factor (GEF) activity and its ability to bind
CC       clathrin. Acts as a GEF for Arf and Rab, by exchanging bound GDP
CC       for free GTP. Binds phosphatidylinositol 4,5-bisphosphate, which
CC       is required for GEF activity. May also act as a E3 ubiquitin-
CC       protein ligase which accepts ubiquitin from an E2 ubiquitin-
CC       conjugating enzyme in the form of a thioester and then directly
CC       transfers the ubiquitin to targeted substrates.
CC       {ECO:0000269|PubMed:15642342, ECO:0000269|PubMed:8861955,
CC       ECO:0000269|PubMed:9233772}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with TSC2; interaction is inhibited by TSC1.
CC       Interacts with PKM, ARF1 and ARF6. Forms a ternary complex with
CC       clathrin heavy chain (CLTC) and HSPA1A.
CC       {ECO:0000269|PubMed:12650930, ECO:0000269|PubMed:15642342,
CC       ECO:0000269|PubMed:16464865, ECO:0000269|PubMed:8861955,
CC       ECO:0000269|PubMed:9233772}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein.
CC       Cytoplasm, cytosol. Golgi apparatus. Note=Recruited onto actin-
CC       rich surface protrusions.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:8861955}.
CC   -!- DISEASE: Macrocephaly, dysmorphic facies, and psychomotor
CC       retardation (MDFPMR) [MIM:617011]: An autosomal recessive syndrome
CC       characterized by large head and somatic overgrowth, intellectual
CC       disability, and facial dysmorphism. Seizures, hypotonia and ataxic
CC       gait are observed in some patients. {ECO:0000269|PubMed:26138117}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U50078; AAD12586.1; -; mRNA.
DR   EMBL; AC073167; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC118274; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC040929; AAH40929.1; -; mRNA.
DR   CCDS; CCDS45277.1; -.
DR   PIR; S71752; S71752.
DR   RefSeq; NP_003913.3; NM_003922.3.
DR   UniGene; Hs.210385; -.
DR   PDB; 4O2W; X-ray; 2.00 A; A/B/C/D=3975-4360.
DR   PDB; 4QT6; X-ray; 1.64 A; A=2035-2192.
DR   PDBsum; 4O2W; -.
DR   PDBsum; 4QT6; -.
DR   ProteinModelPortal; Q15751; -.
DR   SMR; Q15751; -.
DR   BioGrid; 114439; 53.
DR   IntAct; Q15751; 8.
DR   MINT; MINT-8330052; -.
DR   STRING; 9606.ENSP00000390158; -.
DR   iPTMnet; Q15751; -.
DR   PhosphoSitePlus; Q15751; -.
DR   BioMuta; HERC1; -.
DR   DMDM; 296434522; -.
DR   EPD; Q15751; -.
DR   MaxQB; Q15751; -.
DR   PaxDb; Q15751; -.
DR   PeptideAtlas; Q15751; -.
DR   PRIDE; Q15751; -.
DR   Ensembl; ENST00000443617; ENSP00000390158; ENSG00000103657.
DR   GeneID; 8925; -.
DR   KEGG; hsa:8925; -.
DR   UCSC; uc002amp.4; human.
DR   CTD; 8925; -.
DR   DisGeNET; 8925; -.
DR   GeneCards; HERC1; -.
DR   HGNC; HGNC:4867; HERC1.
DR   HPA; HPA049749; -.
DR   MalaCards; HERC1; -.
DR   MIM; 605109; gene.
DR   MIM; 617011; phenotype.
DR   neXtProt; NX_Q15751; -.
DR   OpenTargets; ENSG00000103657; -.
DR   PharmGKB; PA29242; -.
DR   eggNOG; KOG1426; Eukaryota.
DR   eggNOG; COG5021; LUCA.
DR   eggNOG; COG5184; LUCA.
DR   GeneTree; ENSGT00870000136376; -.
DR   HOGENOM; HOG000168589; -.
DR   HOVERGEN; HBG053919; -.
DR   InParanoid; Q15751; -.
DR   KO; K10594; -.
DR   OMA; HHYQDGI; -.
DR   OrthoDB; EOG091G000E; -.
DR   PhylomeDB; Q15751; -.
DR   TreeFam; TF106426; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q15751; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; HERC1; human.
DR   GeneWiki; HERC1; -.
DR   GenomeRNAi; 8925; -.
DR   PRO; PR:Q15751; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000103657; -.
DR   CleanEx; HS_HERC1; -.
DR   ExpressionAtlas; Q15751; baseline and differential.
DR   Genevisible; Q15751; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; TAS:ProtInc.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:InterPro.
DR   GO; GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl.
DR   GO; GO:0010507; P:negative regulation of autophagy; IEA:Ensembl.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; IEA:UniProtKB-KW.
DR   CDD; cd00078; HECTc; 1.
DR   Gene3D; 2.130.10.10; -; 2.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR016186; C-type_lectin-like/link.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR000569; HECT_dom.
DR   InterPro; IPR009091; RCC1/BLIP-II.
DR   InterPro; IPR000408; Reg_chr_condens.
DR   InterPro; IPR003877; SPRY_dom.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF00632; HECT; 1.
DR   Pfam; PF00415; RCC1; 10.
DR   Pfam; PF00622; SPRY; 1.
DR   Pfam; PF00400; WD40; 2.
DR   PRINTS; PR00633; RCCNDNSATION.
DR   SMART; SM00119; HECTc; 1.
DR   SMART; SM00449; SPRY; 1.
DR   SMART; SM00320; WD40; 5.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF50978; SSF50978; 2.
DR   SUPFAM; SSF50985; SSF50985; 2.
DR   SUPFAM; SSF56204; SSF56204; 1.
DR   PROSITE; PS50188; B302_SPRY; 1.
DR   PROSITE; PS50237; HECT; 1.
DR   PROSITE; PS00626; RCC1_2; 4.
DR   PROSITE; PS50012; RCC1_3; 14.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 3.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Disease mutation;
KW   Golgi apparatus; Guanine-nucleotide releasing factor; Membrane;
KW   Mental retardation; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Transferase; Transport; Ubl conjugation pathway; WD repeat.
FT   CHAIN         1   4861       Probable E3 ubiquitin-protein ligase
FT                                HERC1.
FT                                /FTId=PRO_0000328871.
FT   REPEAT      371    420       RCC1 1.
FT   REPEAT      421    475       RCC1 2.
FT   REPEAT      476    528       RCC1 3.
FT   REPEAT      529    578       RCC1 4.
FT   REPEAT      580    631       RCC1 5.
FT   REPEAT      633    682       RCC1 6.
FT   REPEAT      683    735       RCC1 7.
FT   DOMAIN     2002   2193       B30.2/SPRY. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     3426   3465       WD 1.
FT   REPEAT     3484   3522       WD 2.
FT   REPEAT     3524   3572       WD 3.
FT   REPEAT     3580   3619       WD 4.
FT   REPEAT     3624   3663       WD 5.
FT   REPEAT     3667   3713       WD 6.
FT   REPEAT     3745   3784       WD 7.
FT   REPEAT     3996   4044       RCC1 8.
FT   REPEAT     4046   4099       RCC1 9.
FT   REPEAT     4101   4151       RCC1 10.
FT   REPEAT     4153   4203       RCC1 11.
FT   REPEAT     4205   4256       RCC1 12.
FT   REPEAT     4258   4308       RCC1 13.
FT   REPEAT     4310   4360       RCC1 14.
FT   DOMAIN     4501   4848       HECT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00104}.
FT   COMPBIAS   1349   1378       Glu-rich.
FT   ACT_SITE   4811   4811       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00104}.
FT   MOD_RES    1342   1342       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1406   1406       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1428   1428       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1491   1491       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1512   1512       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1517   1517       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1521   1521       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2422   2422       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2701   2701       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2706   2706       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    2710   2710       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    2720   2720       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2723   2723       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    4857   4857       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VARIANT    1088   1088       L -> F (in dbSNP:rs1063423).
FT                                /FTId=VAR_042556.
FT   VARIANT    1278   1278       L -> F (in dbSNP:rs3764187).
FT                                /FTId=VAR_042557.
FT   VARIANT    1411   1411       G -> V (in dbSNP:rs36089909).
FT                                /FTId=VAR_042558.
FT   VARIANT    1447   1447       H -> N (in dbSNP:rs7162519).
FT                                /FTId=VAR_042559.
FT   VARIANT    1572   1572       S -> A (in dbSNP:rs16947363).
FT                                /FTId=VAR_042560.
FT   VARIANT    1696   1696       G -> A (in dbSNP:rs2255243).
FT                                {ECO:0000269|PubMed:8861955}.
FT                                /FTId=VAR_042561.
FT   VARIANT    1995   1995       T -> A (in dbSNP:rs2228512).
FT                                /FTId=VAR_042562.
FT   VARIANT    2220   2220       I -> V (in dbSNP:rs2228510).
FT                                {ECO:0000269|PubMed:8861955}.
FT                                /FTId=VAR_042563.
FT   VARIANT    2816   2816       A -> T (in dbSNP:rs35122568).
FT                                /FTId=VAR_042564.
FT   VARIANT    3152   3152       S -> F (in dbSNP:rs2228513).
FT                                /FTId=VAR_042565.
FT   VARIANT    3517   3517       G -> R (in dbSNP:rs7182782).
FT                                /FTId=VAR_042566.
FT   VARIANT    3722   3722       E -> D (in dbSNP:rs2229749).
FT                                {ECO:0000269|PubMed:8861955}.
FT                                /FTId=VAR_042567.
FT   VARIANT    4394   4394       I -> V (in dbSNP:rs2228516).
FT                                /FTId=VAR_057122.
FT   VARIANT    4520   4520       G -> E (in MDFPMR).
FT                                {ECO:0000269|PubMed:26138117}.
FT                                /FTId=VAR_076995.
FT   CONFLICT   1532   1532       R -> Q (in Ref. 1; AAD12586).
FT                                {ECO:0000305}.
FT   STRAND     2035   2046       {ECO:0000244|PDB:4QT6}.
FT   TURN       2047   2049       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2050   2053       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2055   2065       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2069   2080       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2088   2093       {ECO:0000244|PDB:4QT6}.
FT   TURN       2102   2104       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2106   2112       {ECO:0000244|PDB:4QT6}.
FT   TURN       2113   2115       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2117   2127       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2136   2142       {ECO:0000244|PDB:4QT6}.
FT   TURN       2143   2146       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2147   2152       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2158   2161       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2167   2175       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2178   2180       {ECO:0000244|PDB:4QT6}.
FT   STRAND     2183   2187       {ECO:0000244|PDB:4QT6}.
FT   STRAND     3999   4004       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4011   4013       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4015   4022       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4024   4026       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4029   4034       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4036   4043       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4048   4052       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4055   4057       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4060   4063       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4067   4072       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4074   4076       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4081   4086       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4093   4098       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4103   4107       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4110   4112       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4116   4118       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4122   4127       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4129   4131       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4136   4141       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4143   4150       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4155   4159       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4162   4164       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4168   4170       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4174   4179       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4181   4183       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4188   4193       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4195   4202       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4208   4212       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4215   4217       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4221   4223       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4227   4232       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4234   4236       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4237   4239       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4241   4246       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4248   4255       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4260   4264       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4266   4268       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4273   4278       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4286   4288       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4293   4298       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4300   4307       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4312   4316       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4325   4327       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4331   4336       {ECO:0000244|PDB:4O2W}.
FT   HELIX      4338   4340       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4347   4350       {ECO:0000244|PDB:4O2W}.
FT   STRAND     4352   4358       {ECO:0000244|PDB:4O2W}.
SQ   SEQUENCE   4861 AA;  532228 MW;  31B2C1A1430B9622 CRC64;
     MATMIPPVKL KWLEHLNSSW ITEDSESIAT REGVAVLYSK LVSNKEVVPL PQQVLCLKGP
     QLPDFERESL SSDEQDHYLD ALLSSQLALA KMVCSDSPFA GALRKRLLVL QRVFYALSNK
     YHDKGKVKQQ QHSPESSSGS ADVHSVSERP RSSTDALIEM GVRTGLSLLF ALLRQSWMMP
     VSGPGLSLCN DVIHTAIEVV SSLPPLSLAN ESKIPPMGLD CLSQVTTFLK GVTIPNSGAD
     TLGRRLASEL LLGLAAQRGS LRYLLEWIEM ALGASAVVHT MEKGKLLSSQ EGMISFDCFM
     TILMQMRRSL GSSADRSQWR EPTRTSDGLC SLYEAALCLF EEVCRMASDY SRTCASPDSI
     QTGDAPIVSE TCEVYVWGSN SSHQLVEGTQ EKILQPKLAP SFSDAQTIEA GQYCTFVIST
     DGSVRACGKG SYGRLGLGDS NNQSTLKKLT FEPHRSIKKV SSSKGSDGHT LAFTTEGEVF
     SWGDGDYGKL GHGNSSTQKY PKLIQGPLQG KVVVCVSAGY RHSAAVTEDG ELYTWGEGDF
     GRLGHGDSNS RNIPTLVKDI SNVGEVSCGS SHTIALSKDG RTVWSFGGGD NGKLGHGDTN
     RVYKPKVIEA LQGMFIRKVC AGSQSSLALT STGQVYAWGC GACLGCGSSE ATALRPKLIE
     ELAATRIVDV SIGDSHCLAL SHDNEVYAWG NNSMGQCGQG NSTGPITKPK KVSGLDGIAI
     QQISAGTSHS LAWTALPRDR QVVAWHRPYC VDLEESTFSH LRSFLERYCD KINSEIPPLP
     FPSSREHHSF LKLCLKLLSN HLALALAGGV ATSILGRQAG PLRNLLFRLM DSTVPDEIQE
     VVIETLSVGA TMLLPPLRER MELLHSLLPQ GPDRWESLSK GQRMQLDIIL TSLQDHTHVA
     SLLGYSSPSD AADLSSVCTG YGNLSDQPYG TQSCHPDTHL AEILMKTLLR NLGFYTDQAF
     GELEKNSDKF LLGTSSSENS QPAHLHELLC SLQKQLLAFC HINNISENSS SVALLHKHLQ
     LLLPHATDIY SRSANLLKES PWNGSVGEKL RDVIYVSAAG SMLCQIVNSL LLLPVSVARP
     LLSYLLDLLP PLDCLNRLLP AADLLEDQEL QWPLHGGPEL IDPAGLPLPQ PAQSWVWLVD
     LERTIALLIG RCLGGMLQGS PVSPEEQDTA YWMKTPLFSD GVEMDTPQLD KCMSCLLEVA
     LSGNEEQKPF DYKLRPEIAV YVDLALGCSK EPARSLWISM QDYAVSKDWD SATLSNESLL
     DTVSRFVLAA LLKHTNLLSQ ACGESRYQPG KHLSEVYRCV YKVRSRLLAC KNLELIQTRS
     SSRDRWISEN QDSADVDPQE HSFTRTIDEE AEMEEQAERD REEGHPEPED EEEEREHEVM
     TAGKIFQCFL SAREVARSRD RDRMNSGAGS GARADDPPPQ SQQERRVSTD LPEGQDVYTA
     ACNSVIHRCA LLILGVSPVI DELQKRREEG QLQQPSTSAS EGGGLMTRSE SLTAESRLVH
     TSPNYRLIKS RSESDLSQPE SDEEGYALSG RRNVDLDLAA SHRKRGPMHS QLESLSDSWA
     RLKHSRDWLC NSSYSFESDF DLTKSLGVHT LIENVVSFVS GDVGNAPGFK EPEESMSTSP
     QASIIAMEQQ QLRAELRLEA LHQILVLLSG MEEKGSISLA GSRLSSGFQS STLLTSVRLQ
     FLAGCFGLGT VGHTGGKGES GRLHHYQDGI RAAKRNIQIE IQVAVHKIYQ QLSATLERAL
     QANKHHIEAQ QRLLLVTVFA LSVHYQPVDV SLAISTGLLN VLSQLCGTDT MLGQPLQLLP
     KTGVSQLSTA LKVASTRLLQ ILAITTGTYA DKLSPKVVQS LLDLLCSQLK NLLSQTGVLH
     MASFGEGEQE DGEEEEKKVD SSGETEKKDF RAALRKQHAA ELHLGDFLVF LRRVVSSKAI
     QSKMASPKWT EVLLNIASQK CSSGIPLVGN LRTRLLALHV LEAVLPACES GVEDDQMAQI
     VERLFSLLSD CMWETPIAQA KHAIQIKEKE QEIKLQKQGE LEEEDENLPI QEVSFDPEKA
     QCCLVENGQI LTHGSGGKGY GLASTGVTSG CYQWKFYIVK ENRGNEGTCV GVSRWPVHDF
     NHRTTSDMWL YRAYSGNLYH NGEQTLTLSS FTQGDFITCV LDMEARTISF GKNGEEPKLA
     FEDVDAAELY PCVMFYSSNP GEKVKICDMQ MRGTPRDLLP GDPICSPVAA VLAEATIQLI
     RILHRTDRWT YCINKKMMER LHKIKICIKE SGQKLKKSRS VQSREENEMR EEKESKEEEK
     GKHTRHGLAD LSELQLRTLC IEVWPVLAVI GGVDAGLRVG GRCVHKQTGR HATLLGVVKE
     GSTSAKVQWD EAEITISFPT FWSPSDTPLY NLEPCEPLPF DVARFRGLTA SVLLDLTYLT
     GVHEDMGKQS TKRHEKKHRH ESEEKGDVEQ KPESESALDM RTGLTSDDVK SQSTTSSKSE
     NEIASFSLDP TLPSVESQHQ ITEGKRKNHE HMSKNHDVAQ SEIRAVQLSY LYLGAMKSLS
     ALLGCSKYAE LLLIPKVLAE NGHNSDCASS PVVHEDVEMR AALQFLMRHM VKRAVMRSPI
     KRALGLADLE RAQAMIYKLV VHGLLEDQFG GKIKQEIDQQ AEESDPAQQA QTPVTTSPSA
     SSTTSFMSSS LEDTTTATTP VTDTETVPAS ESPGVMPLSL LRQMFSSYPT TTVLPTRRAQ
     TPPISSLPTS PSDEVGRRQS LTSPDSQSAR PANRTALSDP SSRLSTSPPP PAIAVPLLEM
     GFSLRQIAKA MEATGARGEA DAQNITVLAM WMIEHPGHED EEEPQSGSTA DSRPGAAVLG
     SGGKSNDPCY LQSPGDIPSA DAAEMEEGFS ESPDNLDHTE NAASGSGPSA RGRSAVTRRH
     KFDLAARTLL ARAAGLYRSV QAHRNQSRRE GISLQQDPGA LYDFNLDEEL EIDLDDEAME
     AMFGQDLTSD NDILGMWIPE VLDWPTWHVC ESEDREEVVV CELCECSVVS FNQHMKRNHP
     GCGRSANRQG YRSNGSYVDG WFGGECGSGN PYYLLCGTCR EKYLAMKTKS KSTSSERYKG
     QAPDLIGKQD SVYEEDWDML DVDEDEKLTG EEEFELLAGP LGLNDRRIVP EPVQFPDSDP
     LGASVAMVTA TNSMEETLMQ IGCHGSVEKS SSGRITLGEQ AAALANPHDR VVALRRVTAA
     AQVLLARTMV MRALSLLSVS GSSCSLAAGL ESLGLTDIRT LVRLMCLAAA GRAGLSTSPS
     AMASTSERSR GGHSKANKPI SCLAYLSTAV GCLASNAPSA AKLLVQLCTQ NLISAATGVN
     LTTVDDSIQR KFLPSFLRGI AEENKLVTSP NFVVTQALVA LLADKGAKLR PNYDKSEVEK
     KGPLELANAL AACCLSSRLS SQHRQWAAQQ LVRTLAAHDR DNQTTLQTLA DMGGDLRKCS
     FIKLEAHQNR VMTCVWCNKK GLLATSGNDG TIRVWNVTKK QYSLQQTCVF NRLEGDAEES
     LGSPSDPSFS PVSWSISGKY LAGALEKMVN IWQVNGGKGL VDIQPHWVSA LAWPEEGPAT
     AWSGESPELL LVGRMDGSLG LIEVVDVSTM HRRELEHCYR KDVSVTCIAW FSEDRPFAVG
     YFDGKLLLGT KEPLEKGGIV LIDAHKDTLI SMKWDPTGHI LMTCAKEDSV KLWGSISGCW
     CCLHSLCHPS IVNGIAWCRL PGKGSKLQLL MATGCQSGLV CVWRIPQDTT QTNVTSAEGW
     WEQESNCQDG YRKSSGAKCV YQLRGHITPV RTVAFSSDGL ALVSGGLGGL MNIWSLRDGS
     VLQTVVIGSG AIQTTVWIPE VGVAACSNRS KDVLVVNCTA EWAAANHVLA TCRTALKQQG
     VLGLNMAPCM RAFLERLPMM LQEQYAYEKP HVVCGDQLVH SPYMQCLASL AVGLHLDQLL
     CNPPVPPHHQ NCLPDPASWN PNEWAWLECF STTIKAAEAL TNGAQFPESF TVPDLEPVPE
     DELVFLMDNS KWINGMDEQI MSWATSRPED WHLGGKCDVY LWGAGRHGQL AEAGRNVMVP
     AAAPSFSQAQ QVICGQNCTF VIQANGTVLA CGEGSYGRLG QGNSDDLHVL TVISALQGFV
     VTQLVTSCGS DGHSMALTES GEVFSWGDGD YGKLGHGNSD RQRRPRQIEA LQGEEVVQMS
     CGFKHSAVVT SDGKLFTFGN GDYGRLGLGN TSNKKLPERV TALEGYQIGQ VACGLNHTLA
     VSADGSMVWA FGDGDYGKLG LGNSTAKSSP QKIDVLCGIG IKKVACGTQF SVALTKDGHV
     YTFGQDRLIG LPEGRARNHN RPQQIPVLAG VIIEDVAVGA EHTLALASNG DVYAWGSNSE
     GQLGLGHTNH VREPTLVTGL QGKNVRQISA GRCHSAAWTA PPVPPRAPGV SVPLQLGLPD
     TVPPQYGALR EVSIHTVRAR LRLLYHFSDL MYSSWRLLNL SPNNQNSTSH YNAGTWGIVQ
     GQLRPLLAPR VYTLPMVRSI GKTMVQGKNY GPQITVKRIS TRGRKCKPIF VQIARQVVKL
     NASDLRLPSR AWKVKLVGEG ADDAGGVFDD TITEMCQELE TGIVDLLIPS PNATAEVGYN
     RDRFLFNPSA CLDEHLMQFK FLGILMGVAI RTKKPLDLHL APLVWKQLCC VPLTLEDLEE
     VDLLYVQTLN SILHIEDSGI TEESFHEMIP LDSFVGQSAD GKMVPIIPGG NSIPLTFSNR
     KEYVERAIEY RLHEMDRQVA AVREGMSWIV PVPLLSLLTA KQLEQMVCGM PEISVEVLKK
     VVRYREVDEQ HQLVQWFWHT LEEFSNEERV LFMRFVSGRS RLPANTADIS QRFQIMKVDR
     PYDSLPTSQT CFFQLRLPPY SSQLVMAERL RYAINNCRSI DMDNYMLSRN VDNAEGSDTD
     Y
//
